Study title: Quach et al. Thyroid and hepatic function after high-dose (131) I-metaiodobenzylguanidine ((131 I) -MIBG) therapy for neuroblastoma Pediatr Blood Cancer. 2010 Sep 9
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: META-IODOBENZYLGUANIDINE | |||||
ATC code: | |||||
Document link: 2011-09 GE response 131 Meta-lodobenzylguanidine.doc | |||||
Document date: 2013-12-04 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |